An MoU is different from a contract. MOUs are not firm like contracts. Even contracts can be terminated. Thus, there are varying levels of risk when it comes to the fruition of the proposals
The Board of Directors of HWGB is pleased to announce that Astramern Nutra V Capsule (previously known as “Astramune-V”) has on 24 August 2020 been informed by the NPRA that the product registration approval has been obtained from 21 August 2020 to 21 August 2025.
The vaccines mentioned by Khairy are the ones by Sinopharm.
Titijaya has formal agreement with Sinopharm, once the vaccines are final approved. Titijaya as the partner of Sinopharm in Malaysia, according to the agreement, Titijaya has the right to distribute the medical product to Indonesia, Thailand, Singapore, Australia and Malaysia.
The Board of Directors of HWGB is pleased to announce that Astramern Nutra V Capsule (previously known as “Astramune-V”) has on 24 August 2020 been informed by the NPRA that the product registration approval has been obtained from 21 August 2020 to 21 August 2025.
On 25 August 2020, FDA has responded to EBI’s 2nd communication with FDA by requesting EBI to provide further information on the Investigational New Drug Application (IND) which proposes the use of existing poliomyelitis virus vaccines for prevention of the Diseases.
Further announcement on the material development of the above matter shall be made in due course.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
yorkyork
2,773 posts
Posted by yorkyork > 2020-08-25 14:25 | Report Abuse
An MoU is different from a contract. MOUs are not firm like contracts. Even contracts can be terminated. Thus, there are varying levels of risk when it comes to the fruition of the proposals